Fabrazyme
Links shared publicly online about this topic
European Medicines Agency Reviews Treatment Recommendations For Fabrazyme
medicalnewstoday.com — “The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has reviewed its previous recommendations on the use of Fabrazyme (agalsidase beta) during the ongoing supply” View full resource at medicalnewstoday.com
Most Recently Shared on October 25, 2010 at 1:05 pm By:
MNT Drug Approvals Health News
European Medicines Agency Reviews Treatment Recommendations For Fabrazyme http://mnt.to/3LDS #regulatory
Genzyme Angers Patients Over Fabrazyme Supplies // Pharmalot
pharmalot.com — “Genzyme Angers Patients Over Fabrazyme Supplies // Pharmalot” View full resource at pharmalot.com
Most Recently Shared on August 5, 2011 at 1:50 am By:
Stéphane Potdevin Pharma, Health Social Media, and Health Marketing
RT @pharmalot: Genzyme Angers Patients Over Fabrazyme Supplies http://bit.ly/pGBG0O #genzyme #yam
Genzyme Angers Patients Over Fabrazyme Supplies // Pharmalot
pharmalot.com — “Genzyme Angers Patients Over Fabrazyme Supplies // Pharmalot” View full resource at pharmalot.com
Most Recently Shared on August 5, 2011 at 11:26 am By:
Genzyme's Fabrazyme supplies disrupted again. Guess Sanofi's finding it harder to fix production issues than expected. http://bit.ly/nPHsiD
Pharmacy Europe - EMA reviews treatment recommendations for Fabrazyme
pharmacyeurope.net — “Pharmacy Europe, daily news for pharmacists, hundreds of clinical and best practice articles, online comment and video presentations.” View full resource at pharmacyeurope.net
Most Recently Shared on October 24, 2010 at 4:12 am By:
Drugs and Devices OW OW Health
EMA reviews treatment recommendations for Fabrazyme: The EMA's Committee for Medicinal Products for Human Use (CHM... http://bit.ly/9C62QD
Patients suffer as drug maker rations Fabrazyme medicine
post-gazette.com — “Patients suffer as drug maker rations Fabrazyme medicine” View full resource at post-gazette.com
Most Recently Shared on July 11, 2011 at 2:39 am By:
Drug for Fabry disease being rationed in US, while company turns a huge profit through European deal. THIS IS NOT... http://fb.me/MbISyQQn
European Medicines Agency Updates Treatment Recommendations Because Of Continued Fabrazyme Shortage
medicalnewstoday.com — “The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has been obliged to revise its previous recommendations on the use of Fabrazyme (agalsidase beta). This follow” View full resource at medicalnewstoday.com
Most Recently Shared on July 7, 2010 at 10:29 am By:
Urology & Nephrology OW Health
European Medicines Agency Updates Treatment Recommendations Because Of Continued Fabrazyme Shortage: The European ... http://mnt.to/f/3FMf
More supply woes as Genzyme scraps Fabrazyme batch - FiercePharma
fiercepharma.com — “Yet another problem at its Allston Landing, MA, plant has disrupted Genzyme's Fabrazyme supply and prompted a re-think of its manufacturing efforts. The news is sure to disappoint Fabry disease... Read more...” View full resource at fiercepharma.com
Most Recently Shared on March 24, 2011 at 1:21 pm By:
More supply woes as Genzyme scraps Fabrazyme batch. http://bit.ly/fSvxb5
Genzyme's Fabrazyme Should Be Given in Full Dose, EU Says - Bloomberg
bloomberg.com — “Genzyme Corp.'s Fabrazyme drug for Fabry disease should be given in a full dose after patients receiving a lesser amount reported side effects, the European Medicines Agency said in an e-mailed statement. Patients also can be given a full dose of Shire Plc's Replagal, the agency said.” View full resource at bloomberg.com
Most Recently Shared on October 22, 2010 at 11:20 am By:
Bloomberg: Genzyme’s Fabrazyme Should Be Given in Full Dose, EU Says. http://bit.ly/dawfCu
Genzyme Sees End to Fabrazyme Rationing - WSJ.com
online.wsj.com — “Genzyme expects to stop rationing its rare-disease treatment Fabrazyme during the first half of next year, ending a shortage that began in 2009.” View full resource at online.wsj.com
Most Recently Shared on September 15, 2010 at 9:42 pm By:
Genzyme Sees End to Drug's Rationing http://on.wsj.com/d1oxwR
FDA Alert: Genzyme Products, Marketed as Cerezyme, Fabrayzme, Myozyme, Aldurazyme, and Thyrogen
drugs.com — “FDA Alert: Genzyme Products, Marketed as Cerezyme, Fabrayzme, Myozyme, Aldurazyme, and Thyrogen” View full resource at drugs.com
Most Recently Shared on November 14, 2009 at 3:51 am By:
FDA Alert - FDA Warns of Potential for Foreign Particle Contamination in Several Genzyme Products - http://bit.ly/4puEJt
Genzyme Successfully Meets First Milestones of FDA Consent Decree - Drugs.com MedNews
drugs.com — “All Filling and Finishing for U.S. Market Transferred Out of Allston Plant Nov 24, 2010 - Genzyme Corporation (NASDAQ GENZ) announced today that the company has” View full resource at drugs.com
Most Recently Shared on November 24, 2010 at 4:09 pm By:
Drugs and Devices OW OW Health
Genzyme Successfully Meets First Milestones of FDA Consent Decree: All Filling and Finishing for U.S. Mark... http://bit.ly/i9XrVb #drug
Fabry Disease Patients, Getting Sicker, Sue Drug Company to Get Lifesaving Medication - ABC News
abcnews.go.com — “Pharmaceutical company Genzyme cut dosage of Fabrazyme, a drug to treat Fabry disease, in half for 1,200 U.S. patients but continues to sell the full dosage to patients overseas.” View full resource at abcnews.go.com
Most Recently Shared on September 1, 2011 at 2:55 pm By:
SNAPPIN' MINISTRIES Patient Advocate
Fabry Disease Patients, Getting Sicker, Sue Drug Company to Get Lifesaving Medication- ABC News http://t.co/tVZjN5P (via @ABC) #Rare #orphan
Hospira helps Genzyme tackle manufacturing problems | InPharm
inpharm.com — “Hospira helps Genzyme tackle manufacturing problems | InPharm” View full resource at inpharm.com
Most Recently Shared on January 6, 2010 at 9:45 am By:
Pharmafocus Pharma and Health News
Hospira helps Genzyme tackle manufacturing problems. Will work on products including Cerezyme and Fabrazyme. http://ow.ly/TcUg
Current Drug Shortages
fda.gov — “New/Updated Drug Shortages: Diltiazem Injection 4/14/2011, Lorazepam Injection 2 mg/ml (updated) 4/14/2011, Neostigmine methylsulfate injection (updated) 4/14/2011, Cytarabine injection (updated) 4/12/2011, Lorazepam Injection (updated) 4/11/2011, Amphetamine Mixed Salts, ER Capsules 4/11/2011, Methylphenidate HCl 4/5/2011, MVI injectable (Adult and pediatric)(updated) 4/5/2011, Thiotepa for Injection, Bedford 15 mg/mL vial (NDC 55390-0030-10) 3/29/2011, Fabrazyme (agalsidase beta)(updated) 3/25” View full resource at fda.gov
Most Recently Shared on April 15, 2011 at 2:36 pm By:
SNAPPIN' MINISTRIES Patient Advocate
Drug Shortages > Current Drug Shortages http://t.co/88fBkSX via @AddThis
Current Drug Shortages
fda.gov — “New/Updated Drug Shortages: Lorazepam Injection (updated) 4/11/2011, Adderall XR Capsules 4/11/2011, Amphetamine Mixed Salts, ER Capsules 4/11/2011, Methylphenidate HCl 4/5/2011, MVI injectable (Adult and pediatric)(updated) 4/5/2011, Thiotepa for Injection, Bedford 15 mg/mL vial (NDC 55390-0030-10) 3/29/2011, Fabrazyme (agalsidase beta)(updated) 3/25/2011, Avalide (irbesartan and hydrochlorothiazide)Tablets (updated) 3/25/2011, Dexamethasone Injection 3/25/2011, Xeloda 500 Tablets 3/25/2011, Am” View full resource at fda.gov
Most Recently Shared on April 12, 2011 at 10:20 am By:
SNAPPIN' MINISTRIES Patient Advocate
ADDERALL XR CAPSULES JUST ADDED - FDA - Drug Shortages > Current Drug Shortages http://t.co/Sde025X via @AddThis
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MNT Drug Approvals
The latest regulatory affairs / drug approvals news published daily. Articles from research centers, universities and prestigious journals.
-
Stéphane Potdevin
Senior Manager Projects New Medias. Pharmaceutical Industry. Interest for Social Media and uses.
-
FiercePharma
FiercePharma's 140. Join 50,000 pharma insiders on our free newsletter at FiercePharma.com
Advertisement
